Business Description
Achieve Life Sciences Inc
NAICS : 325413
SIC : 2835
ISIN : US0044682039
Description
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address theĀ smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.36 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | -0.33 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 36.7 | |||||
| 3-Year EPS without NRI Growth Rate | 35.2 | |||||
| 3-Year FCF Growth Rate | 37.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 23.41 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.2 | |||||
| 9-Day RSI | 29.4 | |||||
| 14-Day RSI | 35.11 | |||||
| 6-1 Month Momentum % | -11 | |||||
| 12-1 Month Momentum % | 36.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.78 | |||||
| Quick Ratio | 6.78 | |||||
| Cash Ratio | 6.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -51.3 | |||||
| Shareholder Yield % | -38.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -131.03 | |||||
| ROA % | -72.74 | |||||
| ROIC % | -238.08 | |||||
| 3-Year ROIIC % | -73.25 | |||||
| ROC (Joel Greenblatt) % | -59867.06 | |||||
| ROCE % | -93.96 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.55 | |||||
| Price-to-Tangible-Book | 4.87 | |||||
| EV-to-EBIT | -3.62 | |||||
| EV-to-EBITDA | -3.65 | |||||
| EV-to-FCF | -4.38 | |||||
| Price-to-Net-Current-Asset-Value | 4.88 | |||||
| Price-to-Net-Cash | 5.32 | |||||
| Earnings Yield (Greenblatt) % | -27.62 | |||||
| FCF Yield % | -17.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ACHV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Achieve Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.11 | ||
| Beta | 1.94 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.22 | ||
| Volatility % | 51.3 | ||
| 14-Day RSI | 35.11 | ||
| 14-Day ATR ($) | 0.200793 | ||
| 20-Day SMA ($) | 4.37325 | ||
| 12-1 Month Momentum % | 36.45 | ||
| 52-Week Range ($) | 3.1 - 5.59 | ||
| Shares Outstanding (Mil) | 34.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Achieve Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Achieve Life Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Achieve Life Sciences Inc Frequently Asked Questions
What is Achieve Life Sciences Inc(ACHV)'s stock price today?
The current price of ACHV is $4.10. The 52 week high of ACHV is $5.59 and 52 week low is $3.10.
When is next earnings date of Achieve Life Sciences Inc(ACHV)?
The next earnings date of Achieve Life Sciences Inc(ACHV) is 2025-03-28 Est..
Does Achieve Life Sciences Inc(ACHV) pay dividends? If so, how much?
Achieve Life Sciences Inc(ACHV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers